DR. HANS ORLENT: what changed
What changed
DR. HANS ORLENT
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Net result for the year
€219,793
2024 · €249,707-€29,914
Equity
€999,080
2024 · €894,136+€104,945
Cash
€455,094
2024 · €305,196+€149,899
Balance sheet total
€1.1m
2024 · €968,536+€90,876
Largest movements
Assets
- Cash +€149,899
up €149,899 (+49.1%), from €305,196 to €455,094
mainly Net result for the year (+€219,793) and Current investments (+€46,116)
- Current investments -€46,116
down €46,116 (-9.6%), from €480,393 to €434,276
Equity and liabilities
- Reserves +€104,945
up €104,945 (+11.7%), from €894,136 to €999,080
- Tax, wage and social debts -€13,022
down €13,022 (-41.7%), from €31,242 to €18,221
Income statement
- Gross operating margin -€49,816
down €49,816 (-13.4%), from €371,392 to €321,576
- Taxes -€12,979
down €12,979 (-11.6%), from €111,436 to €98,457
- Financial charges -€10,383
down €10,383 (-66.8%), from €15,532 to €5,149
- Financial income -€4,586
down €4,586 (-25.1%), from €18,279 to €13,692
- Depreciation -€4,480
down €4,480 (-36.7%), from €12,221 to €7,741
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€249,707
Gross operating margin
-€49,816
Depreciation
+€4,480
Other operating charges
-€3,354
Financial income
-€4,586
Financial charges
+€10,383
Taxes
+€12,979
Result 2025
€219,793
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€226,131
Investment
+€46,116
Financing
-€122,348
Cash 2024
€305,196
From operations (derived)
+€226,131
Net result for the year
+€219,793
Depreciation
+€7,741
Receivables after one year
+€7,701
Receivables within one year
-€2,558
Deferred charges and accrued income
+€22
Trade debts
+€7,596
Tax, wage and social debts
-€13,022
Other debts
+€4,191
Accrued charges and deferred income
-€5,334
Investment (derived)
+€46,116
Current investments
+€46,116
Financing
-€122,348
Current portion of long-term debt
-€7,500
Contributions, distributions and other
-€114,848
Cash 2025
€455,094
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €968,536 | €1,059,413 | +€90,876 | +9.4% |
| Fixed assets | 21/28 | €102,955 | €95,214 | -€7,741 | -7.5% |
| Tangible fixed assets | 22/27 | €102,955 | €95,214 | -€7,741 | -7.5% |
| Land and buildings | 22 | €101,222 | €94,156 | -€7,066 | -7.0% |
| Plant, machinery and equipment | 23 | €147 | €0 | -€147 | -100% |
| Other tangible fixed assets | 26 | €1,587 | €1,058 | -€529 | -33.3% |
| Current assets | 29/58 | €865,581 | €964,198 | +€98,618 | +11.4% |
| Amounts receivable after more than one year | 29 | €33,404 | €25,703 | -€7,701 | -23.1% |
| Other amounts receivable | 291 | €33,404 | €25,703 | -€7,701 | -23.1% |
| Amounts receivable within one year | 40/41 | €2,787 | €5,346 | +€2,558 | +91.8% |
| Trade receivables | 40 | €2,787 | €5,346 | +€2,558 | +91.8% |
| Current investments | 50/53 | €480,393 | €434,276 | -€46,116 | -9.6% |
| Cash at bank and in hand | 54/58 | €305,196 | €455,094 | +€149,899 | +49.1% |
| Deferred charges and accrued income | 490/1 | €43,801 | €43,780 | -€22 | 0.0% |
| Total equity and liabilities | 10/49 | €968,536 | €1,059,413 | +€90,876 | +9.4% |
| Equity | 10/15 | €894,136 | €999,080 | +€104,945 | +11.7% |
| Reserves | 13 | €894,136 | €999,080 | +€104,945 | +11.7% |
| Distributable reserves | 133 | €894,136 | €999,080 | +€104,945 | +11.7% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €74,401 | €60,332 | -€14,068 | -18.9% |
| Amounts payable within one year | 42/48 | €66,638 | €57,904 | -€8,735 | -13.1% |
| Current portion of amounts payable after more than one year | 42 | €7,500 | €0 | -€7,500 | -100% |
| Trade debts | 44 | €2,444 | €10,041 | +€7,596 | +311% |
| Suppliers | 440/4 | €2,444 | €10,041 | +€7,596 | +311% |
| Taxes, remuneration and social security | 45 | €31,242 | €18,221 | -€13,022 | -41.7% |
| Taxes | 450/3 | €31,242 | €18,221 | -€13,022 | -41.7% |
| Other amounts payable | 47/48 | €25,452 | €29,643 | +€4,191 | +16.5% |
| Accrued charges and deferred income | 492/3 | €7,762 | €2,429 | -€5,334 | -68.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,221 | €7,741 | -€4,480 | -36.7% |
| Other operating charges | 640/8 | €774 | €4,128 | +€3,354 | +433% |
| Gross operating margin | 9900 | €371,392 | €321,576 | -€49,816 | -13.4% |
| Operating profit (loss) | 9901 | €358,396 | €309,707 | -€48,690 | -13.6% |
| Financial income | 75/76B | €18,279 | €13,692 | -€4,586 | -25.1% |
| Recurring financial income | 75 | €18,279 | €13,692 | -€4,586 | -25.1% |
| Financial charges | 65/66B | €15,532 | €5,149 | -€10,383 | -66.8% |
| Recurring financial charges | 65 | €15,532 | €5,149 | -€10,383 | -66.8% |
| Profit (loss) for the period before taxes | 9903 | €361,143 | €318,250 | -€42,893 | -11.9% |
| Income taxes | 67/77 | €111,436 | €98,457 | -€12,979 | -11.6% |
| Profit (loss) for the period | 9904 | €249,707 | €219,793 | -€29,914 | -12.0% |
| Profit (loss) for the period to be appropriated | 9905 | €249,707 | €219,793 | -€29,914 | -12.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.